Expanding newborn screening (NBS) to include detecting genes linked to an increased risk of neurodevelopmental disorders (NDD) may worsen existing health disparities, according to a recent article in Paediatrics. The authors argue that the scarcity of genetics experts and diagnosticians, as well as the lack of adequate genetic information about variants in diverse communities, would result in overdiagnosis and over-treatment.